epcoritamab
abbvie,genmab
['lymphoma', 'epcoritamab', '$gmab']
#genmab announces late-breaking phase 2 trial results of investigational #epcoritamab (#duobodycd3xcd20) in #relapsed #refractory #largebcelllymphoma (#lbcl) patients presented at #eha22 $gmab 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.